+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical R&D Outsourcing Services Market - Global Forecast 2026-2032- Product Image
Pharmaceutical R&D Outsourcing Services Market - Global Forecast 2026-2032- Product Image
Sale

Pharmaceutical R&D Outsourcing Services Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6144714
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical R&D Outsourcing Services Market is projected to reach USD 54.61 Billion in 2026. It is expected to continue growing at a CAGR of 9.20%, reaching USD 92.34 Billion by 2032.

Pharmaceutical R&D Outsourcing Services: Executive Overview

Pharmaceutical R&D outsourcing services support drug discovery, preclinical development, clinical research, regulatory activities, and related data and laboratory work through external specialist providers. Demand is shaped by rising development complexity, pressure to improve research productivity, specialized capability requirements, and the need to coordinate multinational studies. Buyers increasingly evaluate providers on scientific depth, quality systems, technology integration, patient access, and the ability to manage programs across development stages.

How Complexity and Specialization Are Reshaping Outsourced R&D

Pharmaceutical development is becoming more multidisciplinary, data-intensive, and geographically distributed. Outsourcing decisions are moving beyond task execution toward integrated delivery models that connect laboratory research, clinical operations, biostatistics, regulatory support, safety monitoring, and evidence generation. Sponsors are also placing greater emphasis on flexible engagement structures, transparent governance, standardized data practices, risk-based quality management, and access to specialized therapeutic and patient populations.

Artificial Intelligence Is Expanding R&D Capability and Accountability

Artificial intelligence is being applied across target identification, molecule design, protocol development, site selection, patient recruitment, medical coding, safety signal detection, data cleaning, and document generation. Its cumulative impact depends on the quality, interoperability, provenance, and governance of underlying data. Industry leaders must therefore pair AI adoption with human scientific oversight, validation, cybersecurity, privacy protection, explainability, and controls that preserve trial integrity and regulatory compliance. AI is most valuable when embedded into repeatable workflows rather than treated as a standalone technology purchase.

Regional Insights: Delivery Networks Reflect Capability, Regulation, and Patient Access

North America remains an important hub for advanced clinical research, biotechnology activity, regulatory interaction, and data-enabled services. Europe offers sophisticated scientific and clinical infrastructure, while regulatory coordination across the European Union requires careful attention to shared and national processes. Asia-Pacific combines deep manufacturing and research capabilities with expanding clinical infrastructure, particularly across Australia, China, India, Japan, and South Korea. Latin America can support diverse recruitment and selected clinical programs, although sponsors must manage country-specific regulatory and operational conditions. The Middle East is strengthening healthcare and research capacity, with the GCC providing a focal point for infrastructure development. Africa offers important patient diversity and emerging research potential, while requiring sustained investment in sites, training, logistics, ethics oversight, and data systems.

Group Insights: Cross-Border Frameworks Influence Outsourcing Choices

ASEAN offers a varied set of regulatory environments, healthcare systems, and patient populations, making local execution expertise important for multinational programs. BRICS members provide broad scientific, clinical, and patient-access capabilities but require careful management of differing legal, regulatory, and operational conditions. The European Union benefits from shared institutional structures while retaining national implementation considerations. G7 markets generally provide mature research ecosystems, strong compliance expectations, and advanced technology adoption. GCC countries are investing in healthcare modernization and research infrastructure, creating opportunities for regionally coordinated programs. NATO countries collectively encompass substantial clinical and scientific capacity, though sponsors must account for distinct national requirements and data-governance frameworks.

Country Insights: Capabilities and Operating Conditions Differ Materially

Australia combines established clinical research capabilities with access to diverse study populations. Brazil and Mexico provide important Latin American recruitment and research environments, with execution shaped by local regulatory and site conditions. Canada supports sophisticated research, data, and biotechnology activity. China offers substantial scientific, clinical, and digital capabilities, while regulatory, data, and cross-border requirements require close planning. France, Germany, Italy, Spain, and the United Kingdom provide strong European research infrastructure, with differences in approval pathways, contracting, reimbursement contexts, and site performance. India contributes extensive scientific, technology, and clinical-service talent. Japan and South Korea offer advanced healthcare and research systems, with market access, language, and operational localization remaining important. Russia presents a complex operating environment requiring heightened assessment of regulatory, geopolitical, compliance, and continuity risks. The United States remains a major center for pharmaceutical innovation, clinical research, specialist talent, and regulatory engagement.

Priorities for Leaders: Build Resilient, Integrated, and Governed Partnerships

Industry leaders should segment outsourcing decisions by scientific criticality, data sensitivity, development stage, and required geographic reach. Select partners using evidence of quality performance, therapeutic expertise, inspection readiness, patient-access capability, technology interoperability, and business continuity. Establish shared governance with clear accountability, escalation routes, data standards, and measurable service-level outcomes. Introduce AI through controlled use cases with validation, audit trails, human review, and cybersecurity safeguards. Diversify critical operational dependencies where appropriate, strengthen regional contingency plans, and maintain internal capabilities for strategic oversight, vendor governance, and interpretation of high-value scientific outputs.

Research Methodology: Evidence-Based Assessment of Outsourced R&D Dynamics

This executive summary is based on a structured assessment of the pharmaceutical R&D outsourcing services landscape, organized around service scope, buyer priorities, delivery models, technology adoption, regulatory conditions, and geographic operating environments. Regional, group, and country perspectives are synthesized from established industry and public-domain considerations, including research infrastructure, clinical-trial capability, data governance, healthcare systems, scientific talent, and cross-border execution requirements. Findings are presented qualitatively and do not include market estimates, market sizing, market shares, or forecasts.

Conclusion: Outsourcing Advantage Depends on Integration, Trust, and Execution

Pharmaceutical R&D outsourcing is evolving from a capacity supplement into a strategic component of development operating models. The strongest outcomes will come from partnerships that combine scientific specialization, dependable quality systems, integrated data and technology, broad patient access, and disciplined governance. Regional diversity and regulatory complexity make local knowledge essential, while AI increases both productivity opportunities and accountability requirements. Leaders that build resilient, transparent, and carefully governed ecosystems will be better positioned to improve development execution and sustain confidence among regulators, investigators, patients, and internal stakeholders.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pharmaceutical R&D Outsourcing Services Market, by Service Type
7.1. Introduction
7.2. Drug Discovery Services
7.3. Preclinical Research & Development
7.4. Clinical Development Services
8. Pharmaceutical R&D Outsourcing Services Market, by Outsourcing Mode
8.1. Introduction
8.2. Onshore / Domestic Outsourcing
8.3. Nearshore Outsourcing
8.4. Offshore
9. Pharmaceutical R&D Outsourcing Services Market, by Therapeutic Area
9.1. Introduction
9.2. Oncology
9.3. Cardiovascular diseases
9.4. Infectious diseases
9.5. Rare diseases & Orphan drugs
10. Pharmaceutical R&D Outsourcing Services Market, by End-User
10.1. Introduction
10.2. Large Pharmaceutical Companies
10.3. Biotech Firms
10.4. Generic Drug Manufacturers
10.5. Contract R&D Companies
11. Pharmaceutical R&D Outsourcing Services Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Pharmaceutical R&D Outsourcing Services Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Pharmaceutical R&D Outsourcing Services Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. BioDuro-Sundia, Inc.
15.2. Charles River Laboratories International, Inc.
15.3. Crown Bioscience, Inc.
15.4. Eurofins Scientific SE
15.5. Fortrea Holdings Inc.
15.6. Frontage Laboratories, Inc.
15.7. ICON plc
15.8. IQVIA Holdings, Inc.
15.9. Labcorp Holdings Inc.
15.10. Lonza Group Ltd.
15.11. Medpace Holdings, Inc.
15.12. Parexel International Corporation
15.13. Pharmaron, Inc.
15.14. QPS, LLC
15.15. Samsung Biologics Co., Ltd.
15.16. SGS SA
15.17. Syneos Health, Inc.
15.18. Thermo Fisher Scientific Inc.
15.19. Worldwide Clinical Trials, Inc.
15.20. WuXi AppTec Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pharmaceutical R&D Outsourcing Services Market, Years Considered for the Study
FIGURE 2. Global Pharmaceutical R&D Outsourcing Services Market, Research Design
FIGURE 3. Global Pharmaceutical R&D Outsourcing Services Market, Research Framework
FIGURE 4. Global Pharmaceutical R&D Outsourcing Services Market, Data Triangulation
FIGURE 5. Global Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2025 vs 2032 (%)
FIGURE 9. Global Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 11. Global Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 13. Global Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pharmaceutical R&D Outsourcing Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Pharmaceutical R&D Outsourcing Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pharmaceutical R&D Outsourcing Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Pharmaceutical R&D Outsourcing Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Pharmaceutical R&D Outsourcing Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Pharmaceutical R&D Outsourcing Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pharmaceutical R&D Outsourcing Services Market Segmentation & Coverage
TABLE 2. Global Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Drug Discovery Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Drug Discovery Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Drug Discovery Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Preclinical Research & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Preclinical Research & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Preclinical Research & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Clinical Development Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Clinical Development Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Clinical Development Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 14. Global Onshore / Domestic Outsourcing Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Onshore / Domestic Outsourcing Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Onshore / Domestic Outsourcing Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Nearshore Outsourcing Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Nearshore Outsourcing Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Nearshore Outsourcing Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Offshore Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Offshore Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Offshore Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 24. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Cardiovascular diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Cardiovascular diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Cardiovascular diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Infectious diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Infectious diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Infectious diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Rare diseases & Orphan drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Rare diseases & Orphan drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Rare diseases & Orphan drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 37. Global Large Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Large Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Large Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Biotech Firms Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Biotech Firms Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Biotech Firms Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Generic Drug Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Generic Drug Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Generic Drug Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Contract R&D Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Contract R&D Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Contract R&D Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Pharmaceutical R&D Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Pharmaceutical R&D Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 55. North America Pharmaceutical R&D Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. North America Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 57. North America Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 58. North America Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 59. North America Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 60. Latin America Pharmaceutical R&D Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Latin America Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 62. Latin America Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 63. Latin America Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 64. Latin America Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 65. Europe Pharmaceutical R&D Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Europe Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 67. Europe Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 68. Europe Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 69. Europe Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 70. Middle East Pharmaceutical R&D Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Middle East Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 72. Middle East Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 73. Middle East Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 74. Middle East Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 75. Africa Pharmaceutical R&D Outsourcing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Africa Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 77. Africa Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 78. Africa Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 79. Africa Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 80. Global Pharmaceutical R&D Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. ASEAN Pharmaceutical R&D Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. ASEAN Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 83. ASEAN Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 84. ASEAN Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 85. ASEAN Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 86. GCC Pharmaceutical R&D Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. GCC Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 88. GCC Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 89. GCC Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 90. GCC Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 91. European Union Pharmaceutical R&D Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. European Union Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 93. European Union Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 94. European Union Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 95. European Union Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 96. BRICS Pharmaceutical R&D Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. BRICS Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 98. BRICS Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 99. BRICS Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 100. BRICS Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 101. G7 Pharmaceutical R&D Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. G7 Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 103. G7 Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 104. G7 Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 105. G7 Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 106. NATO Pharmaceutical R&D Outsourcing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. NATO Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 108. NATO Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 109. NATO Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 110. NATO Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 111. Global Pharmaceutical R&D Outsourcing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. United States Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 113. United States Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 114. United States Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 115. United States Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 116. United States Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 117. Canada Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 118. Canada Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 119. Canada Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 120. Canada Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 121. Canada Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 122. Mexico Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 123. Mexico Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 124. Mexico Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 125. Mexico Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 126. Mexico Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 127. Brazil Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 128. Brazil Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 129. Brazil Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 130. Brazil Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 131. Brazil Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 132. United Kingdom Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 133. United Kingdom Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 134. United Kingdom Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 135. United Kingdom Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 136. United Kingdom Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 137. Germany Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 138. Germany Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 139. Germany Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 140. Germany Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 141. Germany Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 142. France Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 143. France Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 144. France Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 145. France Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 146. France Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 147. Russia Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 148. Russia Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 149. Russia Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 150. Russia Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 151. Russia Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 152. Italy Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 153. Italy Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 154. Italy Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 155. Italy Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 156. Italy Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 157. Spain Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 158. Spain Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 159. Spain Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 160. Spain Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 161. Spain Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 162. China Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 163. China Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 164. China Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 165. China Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 166. China Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 167. India Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 168. India Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 169. India Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 170. India Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 171. India Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 172. Japan Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 173. Japan Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 174. Japan Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 175. Japan Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 176. Japan Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 177. Australia Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 178. Australia Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 179. Australia Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 180. Australia Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 181. Australia Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 182. South Korea Pharmaceutical R&D Outsourcing Services Market Size, 2017-2032 (USD Million)
TABLE 183. South Korea Pharmaceutical R&D Outsourcing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 184. South Korea Pharmaceutical R&D Outsourcing Services Market Size, by Outsourcing Mode, 2017-2032 (USD Million)
TABLE 185. South Korea Pharmaceutical R&D Outsourcing Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 186. South Korea Pharmaceutical R&D Outsourcing Services Market Size, by End-User, 2017-2032 (USD Million)
TABLE 187. Global Pharmaceutical R&D Outsourcing Services Market Share, by Key Player, 2025
TABLE 188. Global Pharmaceutical R&D Outsourcing Services Market, Key Experts

Companies Mentioned

  • BioDuro-Sundia, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Eurofins Scientific SE
  • Fortrea Holdings Inc.
  • Frontage Laboratories, Inc.
  • ICON plc
  • IQVIA Holdings, Inc.
  • Labcorp Holdings Inc.
  • Lonza Group Ltd.
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • Pharmaron, Inc.
  • QPS, LLC
  • Samsung Biologics Co., Ltd.
  • SGS SA
  • Syneos Health, Inc.
  • Thermo Fisher Scientific Inc.
  • Worldwide Clinical Trials, Inc.
  • WuXi AppTec Co., Ltd.

Related Topics

Related Reports

Drug Discovery Outsourcing Market - Global Forecast 2026-2032 - Product Image

Drug Discovery Outsourcing Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Medical Affairs Outsourcing Market - Global Forecast 2026-2032 - Product Image

Medical Affairs Outsourcing Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Drug Discovery Outsourcing - Global Strategic Business Report - Product Image

Drug Discovery Outsourcing - Global Strategic Business Report

  • Report
  • 390 Pages
  • Global
From
Drug Discovery Services - Global Strategic Business Report - Product Image

Drug Discovery Services - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Preclinical CRO Market Size, Share, Trends, and Forecast by Service, End Use, and Region, 2026-2034 - Product Image

Preclinical CRO Market Size, Share, Trends, and Forecast by Service, End Use, and Region, 2026-2034

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.